UCB challenges Teva generic drug application

03-07-2013

Belgian pharmaceutical company UCB SA has sued drug-maker Teva Pharmaceutical Industries to stop it manufacturing a generic version of epilepsy drug Vimpat.


UCB, Teva, Vimpat, patent infringement, generic

LSIPR